Nicholas Haft
Founder at Delix Therapeutics, Inc.
Nicholas Haft active positions
| Companies | Position | Start | End |
|---|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Director/Board Member | - | - |
| Founder | - | - | |
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Corporate Secretary | - | - | |
| Arcos Ventures SPV LLC | Director/Board Member | 01/04/2015 | - |
| Chief Executive Officer | 01/04/2015 | - |
Career history of Nicholas Haft
Former positions of Nicholas Haft
| Companies | Position | Start | End |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director/Board Member | 01/02/2020 | 23/06/2023 |
| Independent Dir/Board Member | 01/02/2020 | 23/06/2023 |
Training of Nicholas Haft
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Private companies | 2 |
|---|---|
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Health Technology |
| Arcos Ventures SPV LLC |
- Stock Market
- Insiders
- Nicholas Haft
- Experience
